These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1419298)

  • 1. Modulation of tumour marker CA-125 expression in cultured ovarian carcinoma cells.
    Marth C; Zeimet AG; Böck G; Daxenbichler G
    Eur J Cancer; 1992; 28A(12):2002-6. PubMed ID: 1419298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen.
    Imai S; Kiyozuka Y; Maeda H; Noda T; Hosick HL
    Oncology; 1990; 47(2):177-84. PubMed ID: 2314830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Production of CA125 in cell lines derived from human ovarian carcinoma: in relation to the cell cycle].
    Suzuki M; Ma J; Usui N; Furugen Y; Takada M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):710-6. PubMed ID: 1506733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cells.
    Marth C; Zeimet AG; Widschwendter M; Ludescher C; Kaern J; Tropé C; Gastl G; Daxenbichler G; Dapunt O
    Cancer Res; 1997 Sep; 57(17):3818-22. PubMed ID: 9288793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupron retards proliferation of ovarian epithelial tumor cells cultured in serum-free medium.
    Thompson MA; Adelson MD; Kaufman LM
    J Clin Endocrinol Metab; 1991 May; 72(5):1036-41. PubMed ID: 1902482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines.
    Hunakova L; Bodo J; Chovancova J; Sulikova G; Pastorekova S; Sedlak J
    Neoplasma; 2007; 54(6):541-8. PubMed ID: 17949239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marker profile of mesothelial cells versus ovarian carcinoma cells.
    van Niekerk CC; Jap PH; Thomas CM; Smeets DF; Ramaekers FC; Poels LG
    Int J Cancer; 1989 Jun; 43(6):1065-71. PubMed ID: 2659540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of four human epithelial ovarian carcinoma cell lines.
    Hirte HW; Kaiser JS; Bacchetti S
    Cancer; 1994 Aug; 74(3):900-6. PubMed ID: 8039117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of various marker substances in human ovarian cancer cell lines of epithelial origin.
    Sekiya S; Tanaka N; Takamizawa H
    Arch Gynecol Obstet; 1990; 248(2):103-10. PubMed ID: 2078056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane association and shedding of the GPI-anchored Ca-MOv18 antigen in human ovary carcinoma cells.
    Miotti S; Alberti S; Facheris P; Mantovani L; Fornaro M; Stella M; Ménard S; Canevari S; Colnaghi MI
    Int J Cancer; 1992 May; 51(3):499-505. PubMed ID: 1534320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of new ovarian and colon carcinoma cell lines: differentiation is only possible by cytokeratin analysis.
    Möbus VJ; Moll R; Gerharz CD; Kieback DG; Weikel W; Hoffmann G; Kreienberg R
    Br J Cancer; 1994 Mar; 69(3):422-8. PubMed ID: 7510115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of ovarian carcinoma tumor marker CA-125 by gamma-interferon.
    Marth C; Fuith LC; Böck G; Daxenbichler G; Dapunt O
    Cancer Res; 1989 Dec; 49(23):6538-42. PubMed ID: 2510928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA 125 in ovarian cancer.
    van der Burg ME; Lammes FB; Verweij J
    Neth J Med; 1992 Feb; 40(1-2):36-51. PubMed ID: 1579185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
    van Haaften-Day C; Shen Y; Xu F; Yu Y; Berchuck A; Havrilesky LJ; de Bruijn HW; van der Zee AG; Bast RC; Hacker NF
    Cancer; 2001 Dec; 92(11):2837-44. PubMed ID: 11753957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.
    Denkert C; Fürstenberg A; Daniel PT; Koch I; Köbel M; Weichert W; Siegert A; Hauptmann S
    Oncogene; 2003 Nov; 22(54):8653-61. PubMed ID: 14647459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CA 125 expression in cultured human carcinoma cells.
    Marth C; Zeimet AG; Widschwendter M; Daxenbichler G
    Int J Biol Markers; 1998; 13(4):207-9. PubMed ID: 10228902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ca 125 in epithelial ovarian cancers of FIGO stage I].
    Nagele F; Kurz C; Vavra N; Sevelda P
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():291-2. PubMed ID: 8118320
    [No Abstract]   [Full Text] [Related]  

  • 18. [CA 125, a marker of ovarian epithelial tumors].
    Ruibal A
    Med Clin (Barc); 1988 Jun; 91(2):54-7. PubMed ID: 3050307
    [No Abstract]   [Full Text] [Related]  

  • 19. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125.
    Zeimet AG; Marth C; Offner FA; Obrist P; Uhl-Steidl M; Feichtinger H; Stadlmann S; Daxenbichler G; Dapunt O
    Gynecol Oncol; 1996 Sep; 62(3):384-9. PubMed ID: 8812537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholera toxin-induced alteration of the phenotype and behaviour of an ovarian carcinoma cell line, SR8.
    Han X; Papadopoulos AJ; Jones T; Devaja O; Raju KS
    Immunol Cell Biol; 1999 Oct; 77(5):377-84. PubMed ID: 10540202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.